IP Library Granted Patent US 8,822,211
Granted Patent B2
US 8,822,211 · App. 13/915,535 · Granted Sep 2, 2014

Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives

Inventors: Jean-Pierre Hermet (Boulogne, FR); Isabelle Besson-Faure (Aubagne, FR); Sebastien Ribault (Plan de Cuques, FR); Yann Godfrin (Lyons, FR); Anne Monnot des Angles (Saint-Remy, FR)
Assignee: Becton Dickinson Infusion Therapy Systems Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,822,211
App. No.
13/915,535
Granted
Sep 2, 2014
Kind
B2
Abstract

The invention concerns a device and a method for concentrating pathogenic germs potentially present in blood products or derivatives and for detecting said germs comprising the following steps: (a) subjecting a sample of said blood product to a blood cell aggregating treatment, (b) eliminating the aggregates formed at step (a) by passing the treated sample over a first filter allowing through the contaminating germs but not the cell aggregates, (c) selectively lyzing the residual cells of the filtrate obtained at step (b), (d) recuperating the contaminating germs by passing the lysate of step (c) over a second filter to detect the contaminating germs possibly trapped.

Claims (13)

1. A device for concentrating contaminating microbes possibly present in a blood product comprising blood cells comprising:

a first watertight, sterile tank containing at least one blood cell aggregation agent and, optionally, at least one agent for labeling pathogenic microbes;

a second watertight, sterile tank containing at least one lysis agent for blood cells and, optionally, at least one agent for labeling pathogenic microbes;

a first filter located between the first and second tanks and capable of retaining aggregates formed in said first tank;

a second filter located downstream of the second tank and capable of retaining possible contaminating pathogenic microbes; and

a watertight, sterile connector placed between the first tank and the first filter, between the first filter and the second tank, and between the second tank and the second filter.

2. The device according to claim 1 , further comprising a watertight, sterile connector to connect a bag containing the blood product to the first sterile tank.

3. The device according to claim 2 , wherein the watertight, sterile connection connecting the bag containing the blood product to the first sterile tank has a reverse lock valve.

4. The device according to claim 1 , further comprising means for sampling a determined volume of the blood product directly from a storage bag of the product into the first tank.

5. The device according to claim 2 , wherein the first sterile tank is fitted with a sample suctioning system.

6. The device according to claim 5 , wherein the suctioning system is a piston.

7. The device according to claim 1 , wherein the second filter is enclosed in a membrane support having two parts that can be separated for removing the filter.

8. The device according to claim 1 , which is enclosed and sterile.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2014
From: HERMET, JEAN-PIERRE; BESSON-FAURE, ISABELLE; RIBAULT, SEBASTIEN; GODFRIN, YANN; MONNOT DES ANGLES, ANNE
To: HEMOSYSTEM
Reel/Frame 033366/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2014
From: HEMOSYSTEM
To: GENEOHM SCIENCES, INC.
Reel/Frame 033366/0422 →
MERGER Recorded Jul 22, 2014
From: GENEOHM SCIENCES, INC.
To: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Reel/Frame 033367/0288 →
Priority Claims (1)
FR 01 11873 · Sep 13, 2001 · national
Continuity (3)
Division 10795873 · Mar 8, 2004
Continuation PCTFR0203132 · Sep 13, 2002
Related Publication 20140030803A1 · Jan 30, 2014